Published in:
01-06-2018 | Magnetic Resonance
An eight-year prospective controlled study about the safety and diagnostic value of cardiac and non-cardiac 1.5-T MRI in patients with a conventional pacemaker or a conventional implantable cardioverter defibrillator
Authors:
Pierpaolo Lupo, Riccardo Cappato, Giovanni Di Leo, Francesco Secchi, Giacomo D. E. Papini, Sara Foresti, Hussam Ali, Guido M. G. De Ambroggi, Antonio Sorgente, Gianluca Epicoco, Paola M. Cannaò, Francesco Sardanelli
Published in:
European Radiology
|
Issue 6/2018
Login to get access
Abstract
Objectives
To investigate safety and diagnostic value of 1.5-T MRI in carriers of conventional pacemaker (cPM) or conventional implantable defibrillator (cICD).
Methods
We prospectively compared cPM/cICD-carriers undergoing MRI (study group, SG), excluding those device-dependent or implanted <6 weeks before enrolment or prior to 01/01/2000, with cPM/cICD-carriers undergoing chest x-ray, CT or follow-up (reference group, RG).
Results
142 MRI (55 cardiac) were performed in 120 patients with cPM (n=71) or cICD (n=71). In the RG 98 measurements were performed in 95 patients with cPM (n=40) or cICD (n=58). No adverse events were observed. No MRI prolonged/interrupted. All cPM/cICD were correctly reprogrammed after MRI without malfunctions. One temporary communication failure was observed in one cPM-carrier. Immediately after MRI, 12/14 device interrogation parameters did not change significantly (clinically negligible changes of battery voltage and cICD charging time), without significant variations for SG versus RG. Three–12 months after MRI, 9/11 device interrogation parameters did not change significantly (clinically negligible changes of battery impedance/voltage). Non-significant changes of three markers of myocardial necrosis. Non-cardiac MRI: 82/87 diagnostic without artefacts; 4/87 diagnostic with artefacts; 1/87 partially diagnostic. Cardiac MRI: in cPM-carriers, 14/15 diagnostic with artefacts, 1/15 partially diagnostic; in cICD-carriers, 9/40 diagnostic with artefacts, 22 partially diagnostic, nine non-diagnostic.
Conclusions
A favourable risk-benefit ratio of 1.5-T MRI in cPM/cICD carriers was reported.
Key points
• Cooperation between radiologists and cardiac electrophysiologists allowed safe 1.5-T MRI in cPM/cICD-carriers.
• No adverse events for 142 MRI in 71 cPM-carriers and 71 cICD-carriers.
• Ninety-nine per cent (86/87) of non-cardiac MRI in cPM/cICD-carriers were diagnostic.
• All cPM-carrier cardiac MRIs had artefacts, 14 examinations diagnostic, 1 partially diagnostic.
• Twenty-three per cent (9/40) of cardiac MRI in cICD-carriers were non-diagnostic.